159 related articles for article (PubMed ID: 11263543)
1. CF carrier testing in a high risk population: anxiety, risk perceptions, and reproductive plans of carrier by "non-carrier" couples.
Callanan NP; Cheuvront BJ; Sorenson JR
Genet Med; 1999; 1(7):323-7. PubMed ID: 11263543
[TBL] [Abstract][Full Text] [Related]
2. Cystic fibrosis carrier population screening in the primary care setting.
Loader S; Caldwell P; Kozyra A; Levenkron JC; Boehm CD; Kazazian HH; Rowley PT
Am J Hum Genet; 1996 Jul; 59(1):234-47. PubMed ID: 8659530
[TBL] [Abstract][Full Text] [Related]
3. Attitudes towards reproductive issues and carrier testing among adult patients and parents of children with cystic fibrosis (CF).
Henneman L; Bramsen I; Van Os TA; Reuling IE; Heyerman HG; van der Laag J; van der Ploeg HM; ten Kate LP
Prenat Diagn; 2001 Jan; 21(1):1-9. PubMed ID: 11180232
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of a cystic fibrosis carrier testing clinic for couples.
Christie LM; Ingrey AJ; Turner GM; Proos AL; Watts GE
Med J Aust; 2009 Nov; 191(9):499-501. PubMed ID: 19883345
[TBL] [Abstract][Full Text] [Related]
5. Genetic testing for cystic fibrosis. National Institutes of Health Consensus Development Conference Statement on genetic testing for cystic fibrosis.
Arch Intern Med; 1999 Jul; 159(14):1529-39. PubMed ID: 10421275
[TBL] [Abstract][Full Text] [Related]
6. Psychological impact of population-based carrier testing for cystic fibrosis: 3-year follow-up. UK Cystic Fibrosis Follow-Up Study Group.
Axworthy D; Brock DJ; Bobrow M; Marteau TM
Lancet; 1996 May; 347(9013):1443-6. PubMed ID: 8676627
[TBL] [Abstract][Full Text] [Related]
7. Shock, adjust, decide: reproductive decision making in cystic fibrosis (CF) carrier couples--a qualitative study.
Myring J; Beckett W; Jassi R; Roberts T; Sayers R; Scotcher D; McAllister M
J Genet Couns; 2011 Aug; 20(4):404-17. PubMed ID: 21732237
[TBL] [Abstract][Full Text] [Related]
8. Carrier screening for cystic fibrosis in a prenatal setting.
Delvaux I; van Tongerloo A; Messiaen L; Van Loon C; De Bie S; Mortier G; De Paepe A
Genet Test; 2001; 5(2):117-25. PubMed ID: 11551097
[TBL] [Abstract][Full Text] [Related]
9. Highlighting the impact of cascade carrier testing in cystic fibrosis families.
Duguépéroux I; L'Hostis C; Audrézet MP; Rault G; Frachon I; Bernard R; Parent P; Blayau M; Schmitt S; Génin E; Férec C; Scotet V
J Cyst Fibros; 2016 Jul; 15(4):452-9. PubMed ID: 27013383
[TBL] [Abstract][Full Text] [Related]
10. Genetic counseling after implementation of statewide cystic fibrosis newborn screening: Two years' experience in one medical center.
Wheeler PG; Smith R; Dorkin H; Parad RB; Comeau AM; Bianchi DW
Genet Med; 2001; 3(6):411-5. PubMed ID: 11715005
[TBL] [Abstract][Full Text] [Related]
11. Prenatal genetic carrier testing using triple disease screening.
Eng CM; Schechter C; Robinowitz J; Fulop G; Burgert T; Levy B; Zinberg R; Desnick RJ
JAMA; 1997 Oct; 278(15):1268-72. PubMed ID: 9333269
[TBL] [Abstract][Full Text] [Related]
12. "Suddenly Having two Positive People who are Carriers is a Whole New Thing" - Experiences of Couples Both Identified as Carriers of Cystic Fibrosis Through a Population-Based Carrier Screening Program in Australia.
Ioannou L; Delatycki MB; Massie J; Hodgson J; Lewis S
J Genet Couns; 2015 Dec; 24(6):987-1000. PubMed ID: 25925605
[TBL] [Abstract][Full Text] [Related]
13. The impact of population based screening for carriers of cystic fibrosis.
Bekker H; Denniss G; Modell M; Bobrow M; Marteau T
J Med Genet; 1994 May; 31(5):364-8. PubMed ID: 8064812
[TBL] [Abstract][Full Text] [Related]
14. Psychosocial and educational outcomes associated with home- and clinic-based pretest education and cystic fibrosis carrier testing among a population of at-risk relatives.
Cheuvront B; Sorensen JR; Callanan NP; Stearns SC; DeVellis BM
Am J Med Genet; 1998 Feb; 75(5):461-8. PubMed ID: 9489788
[TBL] [Abstract][Full Text] [Related]
15. Adverse psychological effects, reproductive uncertainty, and risk perception in 52 "carrier by non-carrier" CF parental pairs.
Biesecker LG
Genet Med; 2000; 2(3):203. PubMed ID: 11256667
[No Abstract] [Full Text] [Related]
16. Cystic fibrosis heterozygote screening in 5,161 pregnant women.
Witt DR; Schaefer C; Hallam P; Wi S; Blumberg B; Fishbach A; Holtzman J; Kornfeld S; Lee R; Nemzer L; Palmer R
Am J Hum Genet; 1996 Apr; 58(4):823-35. PubMed ID: 8644747
[TBL] [Abstract][Full Text] [Related]
17. Acceptability of carrier screening for cystic fibrosis during pregnancy in a German population.
Jung U; Urner U; Grade K; Coutelle C
Hum Genet; 1994 Jul; 94(1):19-24. PubMed ID: 8034290
[TBL] [Abstract][Full Text] [Related]
18. Involving consumers in the development of an educational program for cystic fibrosis carrier screening.
Myers MF; Bernhardt BA; Tambor ES; Holtzman NA
Am J Hum Genet; 1994 Apr; 54(4):719-26. PubMed ID: 8128971
[TBL] [Abstract][Full Text] [Related]
19. Cystic fibrosis carrier screening in a high-risk population. Participation based on a traditional recruitment process.
Surh LC; Cappelli M; MacDonald NE; Mettler G; Dales RE
Arch Pediatr Adolesc Med; 1994 Jun; 148(6):632-7. PubMed ID: 8193692
[TBL] [Abstract][Full Text] [Related]
20. Ethical considerations in choosing a model for population-based cystic fibrosis carrier screening.
Modra LJ; Massie RJ; Delatycki MB
Med J Aust; 2010 Aug; 193(3):157-60. PubMed ID: 20678044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
